Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Zinc Chelation Specifically Inhibits Early Stages of Dengue Virus Replication by Activation of NF-κB and Induction of Antiviral Response in Epithelial Cells.

Kar M, Khan NA, Panwar A, Bais SS, Basak S, Goel R, Sopory S, Medigeshi GR.

Front Immunol. 2019 Oct 1;10:2347. doi: 10.3389/fimmu.2019.02347. eCollection 2019.

2.

Isolation and molecular characterization of dengue virus clinical isolates from pediatric patients in New Delhi.

Kar M, Nisheetha A, Kumar A, Jagtap S, Shinde J, Singla M, M S, Pandit A, Chandele A, Kabra SK, Krishna S, Roy R, Lodha R, Pattabiraman C, Medigeshi GR.

Int J Infect Dis. 2019 Jul;84S:S25-S33. doi: 10.1016/j.ijid.2018.12.003. Epub 2018 Dec 7.

3.

Position Paper on Road Map for RNA Virus Research in India.

Medigeshi GR, Fink K, Hegde NR.

Front Microbiol. 2018 Jul 31;9:1753. doi: 10.3389/fmicb.2018.01753. eCollection 2018.

4.

Dengue Virus Capsid Interacts with DDX3X-A Potential Mechanism for Suppression of Antiviral Functions in Dengue Infection.

Kumar R, Singh N, Abdin MZ, Patel AH, Medigeshi GR.

Front Cell Infect Microbiol. 2018 Jan 17;7:542. doi: 10.3389/fcimb.2017.00542. eCollection 2017.

5.

Rapid antigen tests for dengue virus serotypes and Zika virus in patient serum.

Bosch I, de Puig H, Hiley M, Carré-Camps M, Perdomo-Celis F, Narváez CF, Salgado DM, Senthoor D, O'Grady M, Phillips E, Durbin A, Fandos D, Miyazaki H, Yen CW, Gélvez-Ramírez M, Warke RV, Ribeiro LS, Teixeira MM, Almeida RP, Muñóz-Medina JE, Ludert JE, Nogueira ML, Colombo TE, Terzian ACB, Bozza PT, Calheiros AS, Vieira YR, Barbosa-Lima G, Vizzoni A, Cerbino-Neto J, Bozza FA, Souza TML, Trugilho MRO, de Filippis AMB, de Sequeira PC, Marques ETA, Magalhaes T, Díaz FJ, Restrepo BN, Marín K, Mattar S, Olson D, Asturias EJ, Lucera M, Singla M, Medigeshi GR, de Bosch N, Tam J, Gómez-Márquez J, Clavet C, Villar L, Hamad-Schifferli K, Gehrke L.

Sci Transl Med. 2017 Sep 27;9(409). pii: eaan1589. doi: 10.1126/scitranslmed.aan1589.

6.

Dengue Virus Entry and Replication Does Not Lead to Productive Infection in Platelets.

Kar M, Singla M, Chandele A, Kabra SK, Lodha R, Medigeshi GR.

Open Forum Infect Dis. 2017 Mar 23;4(2):ofx051. doi: 10.1093/ofid/ofx051. eCollection 2017 Spring.

7.

CD8 T cells protect adult naive mice from JEV-induced morbidity via lytic function.

Jain N, Oswal N, Chawla AS, Agrawal T, Biswas M, Vrati S, Rath S, George A, Bal V, Medigeshi GR.

PLoS Negl Trop Dis. 2017 Feb 2;11(2):e0005329. doi: 10.1371/journal.pntd.0005329. eCollection 2017 Feb.

8.

Platelet activation determines the severity of thrombocytopenia in dengue infection.

Ojha A, Nandi D, Batra H, Singhal R, Annarapu GK, Bhattacharyya S, Seth T, Dar L, Medigeshi GR, Vrati S, Vikram NK, Guchhait P.

Sci Rep. 2017 Jan 31;7:41697. doi: 10.1038/srep41697.

9.

Characterization of Human CD8 T Cell Responses in Dengue Virus-Infected Patients from India.

Chandele A, Sewatanon J, Gunisetty S, Singla M, Onlamoon N, Akondy RS, Kissick HT, Nayak K, Reddy ES, Kalam H, Kumar D, Verma A, Panda H, Wang S, Angkasekwinai N, Pattanapanyasat K, Chokephaibulkit K, Medigeshi GR, Lodha R, Kabra S, Ahmed R, Murali-Krishna K.

J Virol. 2016 Nov 28;90(24):11259-11278. Print 2016 Dec 15.

10.

Etiology of Acute Respiratory Infections in Infants: A Prospective Birth Cohort Study.

Kumar P, Medigeshi GR, Mishra VS, Islam M, Randev S, Mukherjee A, Chaudhry R, Kapil A, Ram Jat K, Lodha R, Kabra SK.

Pediatr Infect Dis J. 2017 Jan;36(1):25-30.

PMID:
27753796
11.

N-Desmethylclozapine, Fluoxetine, and Salmeterol Inhibit Postentry Stages of the Dengue Virus Life Cycle.

Medigeshi GR, Kumar R, Dhamija E, Agrawal T, Kar M.

Antimicrob Agents Chemother. 2016 Oct 21;60(11):6709-6718. doi: 10.1128/AAC.01367-16. Print 2016 Nov.

12.

Identification and characterization of the role of c-terminal Src kinase in dengue virus replication.

Kumar R, Agrawal T, Khan NA, Nakayama Y, Medigeshi GR.

Sci Rep. 2016 Jul 26;6:30490. doi: 10.1038/srep30490.

13.

Correction: Immune Response to Dengue Virus Infection in Pediatric Patients in New Delhi, India-Association of Viremia, Inflammatory Mediators and Monocytes with Disease Severity.

Singla M, Kar M, Sethi T, Kabra SK, Lodha R, Chandele A, Medigeshi GR.

PLoS Negl Trop Dis. 2016 Apr 14;10(4):e0004642. doi: 10.1371/journal.pntd.0004642. eCollection 2016 Apr. No abstract available.

14.

Role of human GRP75 in miRNA mediated regulation of dengue virus replication.

Kakumani PK, Medigeshi GR, Kaur I, Malhotra P, Mukherjee SK, Bhatnagar RK.

Gene. 2016 Jul 15;586(1):7-11. doi: 10.1016/j.gene.2016.03.053. Epub 2016 Mar 30.

PMID:
27039024
15.

Immune Response to Dengue Virus Infection in Pediatric Patients in New Delhi, India--Association of Viremia, Inflammatory Mediators and Monocytes with Disease Severity.

Singla M, Kar M, Sethi T, Kabra SK, Lodha R, Chandele A, Medigeshi GR.

PLoS Negl Trop Dis. 2016 Mar 16;10(3):e0004497. doi: 10.1371/journal.pntd.0004497. eCollection 2016 Mar. Erratum in: PLoS Negl Trop Dis. 2016 Apr;10(4):e0004642.

16.

Dengue NS3, an RNAi suppressor, modulates the human miRNA pathways through its interacting partner.

Kakumani PK, Rajgokul KS, Ponia SS, Kaur I, Mahanty S, Medigeshi GR, Banerjea AC, Chopra AP, Malhotra P, Mukherjee SK, Bhatnagar RK.

Biochem J. 2015 Oct 1;471(1):89-99. doi: 10.1042/BJ20150445. Epub 2015 Jul 28.

PMID:
26221025
17.

Japanese encephalitis virus disrupts cell-cell junctions and affects the epithelial permeability barrier functions.

Agrawal T, Sharvani V, Nair D, Medigeshi GR.

PLoS One. 2013 Jul 24;8(7):e69465. doi: 10.1371/journal.pone.0069465. Print 2013.

18.

Role of RNA interference (RNAi) in dengue virus replication and identification of NS4B as an RNAi suppressor.

Kakumani PK, Ponia SS, S RK, Sood V, Chinnappan M, Banerjea AC, Medigeshi GR, Malhotra P, Mukherjee SK, Bhatnagar RK.

J Virol. 2013 Aug;87(16):8870-83. doi: 10.1128/JVI.02774-12. Epub 2013 Jun 5.

19.

Adaptor protein complexes-1 and 3 are involved at distinct stages of flavivirus life-cycle.

Agrawal T, Schu P, Medigeshi GR.

Sci Rep. 2013;3:1813. doi: 10.1038/srep01813.

20.

Bispidine-amino acid conjugates act as a novel scaffold for the design of antivirals that block Japanese encephalitis virus replication.

Haridas V, Rajgokul KS, Sadanandan S, Agrawal T, Sharvani V, Gopalakrishna MV, Bijesh MB, Kumawat KL, Basu A, Medigeshi GR.

PLoS Negl Trop Dis. 2013;7(1):e2005. doi: 10.1371/journal.pntd.0002005. Epub 2013 Jan 17.

21.

P58(IPK): a novel "CIHD" member of the host innate defense response against pathogenic virus infection.

Goodman AG, Fornek JL, Medigeshi GR, Perrone LA, Peng X, Dyer MD, Proll SC, Knoblaugh SE, Carter VS, Korth MJ, Nelson JA, Tumpey TM, Katze MG.

PLoS Pathog. 2009 May;5(5):e1000438. doi: 10.1371/journal.ppat.1000438. Epub 2009 May 22.

22.

West nile virus capsid degradation of claudin proteins disrupts epithelial barrier function.

Medigeshi GR, Hirsch AJ, Brien JD, Uhrlaub JL, Mason PW, Wiley C, Nikolich-Zugich J, Nelson JA.

J Virol. 2009 Jun;83(12):6125-34. doi: 10.1128/JVI.02617-08. Epub 2009 Apr 15.

23.

West Nile virus entry requires cholesterol-rich membrane microdomains and is independent of alphavbeta3 integrin.

Medigeshi GR, Hirsch AJ, Streblow DN, Nikolich-Zugich J, Nelson JA.

J Virol. 2008 Jun;82(11):5212-9. doi: 10.1128/JVI.00008-08. Epub 2008 Apr 2.

24.

AP-1 membrane-cytoplasm recycling regulated by mu1A-adaptin.

Medigeshi GR, Krikunova M, Radhakrishnan K, Wenzel D, Klingauf J, Schu P.

Traffic. 2008 Jan;9(1):121-32. Epub 2007 Nov 27.

25.

West Nile virus infection activates the unfolded protein response, leading to CHOP induction and apoptosis.

Medigeshi GR, Lancaster AM, Hirsch AJ, Briese T, Lipkin WI, Defilippis V, Früh K, Mason PW, Nikolich-Zugich J, Nelson JA.

J Virol. 2007 Oct;81(20):10849-60. Epub 2007 Aug 8.

26.

A PACS-1, GGA3 and CK2 complex regulates CI-MPR trafficking.

Scott GK, Fei H, Thomas L, Medigeshi GR, Thomas G.

EMBO J. 2006 Oct 4;25(19):4423-35. Epub 2006 Sep 14.

27.

The Src family kinase c-Yes is required for maturation of West Nile virus particles.

Hirsch AJ, Medigeshi GR, Meyers HL, DeFilippis V, Früh K, Briese T, Lipkin WI, Nelson JA.

J Virol. 2005 Sep;79(18):11943-51.

28.

Characterization of the in vitro retrograde transport of MPR46.

Medigeshi GR, Schu P.

Traffic. 2003 Nov;4(11):802-11.

Supplemental Content

Loading ...
Support Center